Accredited Investors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Sell
9,970
-470
-5% -$68.4K 0.06% 95
2026
Q1
$1.51M Sell
10,440
-69
-0.7% -$10.5K 0.08% 84
2025
Q4
$1.51M Sell
10,509
-537
-5% -$79.2K 0.08% 82
2025
Q3
$1.7M Buy
11,046
+34
+0.3% +$5.31K 0.09% 73
2025
Q2
$1.75M Buy
11,012
+306
+3% +$49.9K 0.1% 70
2025
Q1
$1.82M Sell
10,706
-390
-4% -$65.3K 0.11% 65
2024
Q4
$1.86M Sell
11,096
-1,123
-9% -$191K 0.11% 66
2024
Q3
$2.12M Buy
12,219
+486
+4% +$82.5K 0.12% 58
2024
Q2
$1.94M Buy
11,733
+543
+5% +$88.8K 0.12% 56
2024
Q1
$1.82M Buy
11,190
+79
+0.7% +$12.4K 0.12% 63
2023
Q4
$1.63M Sell
11,111
-1,151
-9% -$170K 0.12% 65
2023
Q3
$1.79M Buy
12,262
+185
+2% +$28.3K 0.13% 58
2023
Q2
$1.83M Sell
12,077
-242
-2% -$36.5K 0.13% 56
2023
Q1
$1.83M Sell
12,319
-499
-4% -$71.3K 0.14% 54
2022
Q4
$1.94M Sell
12,818
-930
-7% -$130K 0.16% 51
2022
Q3
$1.74M Buy
13,748
+523
+4% +$74.3K 0.2% 47
2022
Q2
$1.9M Buy
13,225
+577
+5% +$86.7K 0.23% 46
2022
Q1
$1.93M Buy
12,648
+281
+2% +$44K 0.17% 47
2021
Q4
$2.02M Buy
12,367
+175
+1% +$26K 0.18% 47
2021
Q3
$1.71M Buy
12,192
+24
+0.2% +$3.4K 0.18% 44
2021
Q2
$1.64M Buy
12,168
+26
+0.2% +$3.52K 0.17% 45
2021
Q1
$1.64M Sell
12,142
-1,223
-9% -$160K 0.22% 46
2020
Q4
$1.86M Buy
13,365
+1,179
+10% +$165K 0.31% 39
2020
Q3
$1.69M Sell
12,186
-1,366
-10% -$181K 0.35% 36
2020
Q2
$1.62M Buy
13,552
+28
+0.2% +$3.27K 0.33% 37
2020
Q1
$1.49M Buy
13,524
+59
+0.4% +$7.08K 0.35% 37
2019
Q4
$1.68M Buy
13,465
+262
+2% +$32.1K 0.29% 41
2019
Q3
$1.64M Buy
13,203
+189
+1% +$22.3K 0.32% 40
2019
Q2
$1.43M Sell
13,014
-77
-0.6% -$8.21K 0.28% 43
2019
Q1
$1.36M Buy
13,091
+427
+3% +$41.6K 0.27% 40
2018
Q4
$1.16M Buy
12,664
+2,156
+21% +$193K 0.26% 42
2018
Q3
$875K Sell
10,508
-379
-3% -$31K 0.22% 40
2018
Q2
$850K Buy
10,887
+919
+9% +$69.2K 0.22% 40
2018
Q1
$790K Sell
9,968
-786
-7% -$65.5K 0.22% 40
2017
Q4
$988K Sell
10,754
-412
-4% -$37.1K 0.27% 34
2017
Q3
$1.02M Buy
11,166
+646
+6% +$58.8K 0.28% 37
2017
Q2
$917K Sell
10,520
-1,895
-15% -$167K 0.24% 29
2017
Q1
$1.11M Buy
12,415
+137
+1% +$12.1K 0.28% 29
2016
Q4
$1.03M Sell
12,278
-278
-2% -$23.7K 0.27% 28
2016
Q3
$1.13M Sell
12,556
-907
-7% -$78.8K 0.31% 22
2016
Q2
$1.11M Buy
13,463
+1,386
+11% +$114K 0.31% 24
2016
Q1
$994K Buy
12,077
+32
+0.3% +$2.58K 0.25% 28
2015
Q4
$957K Buy
12,045
+620
+5% +$47.4K 0.24% 27
2015
Q3
$822K Buy
11,425
+2,709
+31% +$203K 0.22% 32
2015
Q2
$682K Sell
8,716
-314
-3% -$25.3K 0.18% 33
2015
Q1
$740K Buy
9,030
+18
+0.2% +$1.55K 0.19% 29
2014
Q4
$821K Sell
9,012
-310
-3% -$27.3K 0.24% 28
2014
Q3
$779K Sell
9,322
-563
-6% -$46.1K 0.24% 28
2014
Q2
$777K Buy
9,885
+922
+10% +$74.3K 0.25% 26
2014
Q1
$723K Buy
8,963
+1,466
+20% +$116K 0.24% 26
2013
Q4
$611K Buy
7,497
+310
+4% +$25.3K 0.21% 28
2013
Q3
$544K Buy
7,187
+20
+0.3% +$1.59K 0.2% 28
2013
Q2
$552K Buy
+7,167
New +$562K 0.22% 27

Other funds holding PG

Accredited Investors's PG Position: Q2 2026 in Review

Accredited Investors reduced its Procter & Gamble (PG) stake by 4.5% in Q2 2026, selling an estimated $68.4K and leaving 9,970 shares worth $1.46M. The position accounts for 0.06% of the portfolio, ranked #95.

Accredited Investors first reported a position in PG in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.12M in Q3 2024. 1,982 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Accredited Investors held 9,970 shares of Procter & Gamble worth $1.46M as of Q2 2026.
  • Accredited Investors sold 470 Procter & Gamble shares in Q2 2026, an estimated $68.4K.
  • Procter & Gamble made up 0.06% of Accredited Investors's portfolio in Q2 2026, its #95 holding.
  • Accredited Investors first reported a position in Procter & Gamble in Q2 2013 and has held it in 53 quarters since.
  • Accredited Investors's Procter & Gamble position peaked at $2.12M in Q3 2024.
  • 1,982 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.